Emily Page

717 total citations
10 papers, 447 citations indexed

About

Emily Page is a scholar working on Clinical Psychology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Emily Page has authored 10 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Clinical Psychology, 3 papers in Physiology and 3 papers in Psychiatry and Mental health. Recurrent topics in Emily Page's work include Alzheimer's disease research and treatments (3 papers), COVID-19 and Mental Health (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Emily Page is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), COVID-19 and Mental Health (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Emily Page collaborates with scholars based in United States and China. Emily Page's co-authors include Jennifer G. Duncan, Diana L. Gray, Jaime R. Strickland, Ann Marie Dale, Lisa Hayibor, Thomas Kannampallil, Bradley Evanoff, Robert B. Innis, William Charles Kreisl and Raymond Scott Turner and has published in prestigious journals such as NeuroImage, Neurology and Psychopharmacology.

In The Last Decade

Emily Page

10 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Page United States	7	149	118	117	103	71	10	447
Qian Su China	18	130 0.9×	85 0.7×	48 0.4×	30 0.3×	91 1.3×	56	709
Mengzhou Xue China	10	164 1.1×	40 0.3×	42 0.4×	97 0.9×	99 1.4×	18	557
Hongjuan Lang China	13	117 0.8×	34 0.3×	147 1.3×	49 0.5×	119 1.7×	54	522
Ashley B. Petrone United States	9	38 0.3×	36 0.3×	101 0.9×	71 0.7×	71 1.0×	11	425
Palanimuthu Thangaraju Sivakumar India	13	86 0.6×	101 0.9×	103 0.9×	84 0.8×	50 0.7×	69	618
Omar Fattal United States	11	98 0.7×	66 0.6×	47 0.4×	28 0.3×	178 2.5×	17	579
Xiuying Hu China	9	118 0.8×	50 0.4×	95 0.8×	13 0.1×	74 1.0×	31	407
Elinor Fondell United States	12	35 0.2×	150 1.3×	76 0.6×	44 0.4×	51 0.7×	19	640
Ruifeng Liang China	13	86 0.6×	103 0.9×	80 0.7×	23 0.2×	68 1.0×	34	523

Countries citing papers authored by Emily Page

Since Specialization

Citations

This map shows the geographic impact of Emily Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Page more than expected).

Fields of papers citing papers by Emily Page

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Page. The network helps show where Emily Page may publish in the future.

Co-authorship network of co-authors of Emily Page

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Page. A scholar is included among the top collaborators of Emily Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Page. Emily Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Page, Emily, et al.. (2022). Examination of the COVID-19 Pandemic’s Impact on Mental Health From Three Perspectives: Global, Social, and Individual. Perspectives on Psychological Science. 18(2). 513–526. 3 indexed citations

Lago, Tiffany R., Michael Brownstein, Emily Page, et al.. (2021). The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study. Psychopharmacology. 238(9). 2393–2403. 21 indexed citations

Evanoff, Bradley, Jaime R. Strickland, Ann Marie Dale, et al.. (2020). Work-Related and Personal Factors Associated With Mental Well-Being During the COVID-19 Response: Survey of Health Care and Other Workers. Journal of Medical Internet Research. 22(8). e21366–e21366. 204 indexed citations

Snow, Joseph, et al.. (2020). Medical Symptom Validity Test (MSVT) profiles in individuals being evaluated for Alzheimer’s disease. The Clinical Neuropsychologist. 36(6). 1328–1351. 2 indexed citations

Kreisl, William Charles, Emily Page, Andrew F. Teich, et al.. (2017). ¹¹ C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease. Neurology. 88(10). 1001–1004. 12 indexed citations

Kreisl, William Charles, Chul Hyoung Lyoo, Jeih-San Liow, et al.. (2016). Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease. Neurobiology of Aging. 51. 132–140. 37 indexed citations

Kreisl, William Charles, Chul Hyoung Lyoo, Jeih-San Liow, et al.. (2016). 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease. Neurobiology of Aging. 44. 53–61. 132 indexed citations

Liow, Jeih‐San, Sami S. Zoghbi, Shuo Hu, et al.. (2016). 18F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier. NeuroImage. 138. 134–140. 7 indexed citations

Jenko, Kimberly J., Sami S. Zoghbi, Talakad G. Lohith, et al.. (2015). Blockade of translocator protein (TSPO) to measure specific binding of 11C-(R)-PK 11195 in human brain. 56. 467–467. 1 indexed citations

10.

Teaf, Christopher M., et al.. (2010). ARSENIC CLEANUP CRITERIA FOR SOILS IN THE US AND ABROAD: COMPARING GUIDELINES AND UNDERSTANDING INCONSISTENCIES. ScholarWorks@UMassAmherst (University of Massachusetts Amherst). 15(1). 10. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact